Key Highlights
- Aehr Test Systems surged after posting Q4 non-GAAP EPS of $0.11, crushing the consensus estimate of -$0.01, with revenue up 34% year-over-year to $18.84 million.
- Management guided fiscal 2027 revenue to $130-$150 million, representing 160-200% growth and roughly double the $85 million analyst consensus.
- The guidance is backed by record quarterly bookings of $60.7 million and an effective backlog of $100.6 million.
- CEO Gayn Erickson highlighted accelerating demand across AI processors, silicon photonics, and power semiconductors, alongside a broader semiconductor sector tailwind from softer PPI data and bullish ASML commentary.
Aehr Test Systems (NASDAQ: AEHR) shares surged after the semiconductor test equipment maker delivered a genuinely dramatic earnings beat and issued forward guidance that stands out even in a sector accustomed to volatile, headline-driven moves. The scale of both the trailing quarter's outperformance and the forward guidance gap relative to Wall Street expectations places this report among the more decisive single-day fundamental catalysts in the small-cap semiconductor equipment space this year.
The fourth-quarter results themselves were striking on their own terms. Aehr posted non-GAAP earnings per share of $0.11, crushing the consensus estimate of negative $0.01 — a swing from an expected loss to an actual profit that represents a substantially larger beat than the raw numbers alone might suggest. Revenue rose 34% year-over-year to $18.84 million, a growth rate that already signals a business inflecting meaningfully upward even before accounting for the forward guidance that followed.
That forward guidance is where today's story becomes genuinely exceptional. Management guided fiscal 2027 revenue to a range of $130 million to $150 million, representing 160% to 200% growth from current levels — and, most strikingly, landing at roughly double the $85 million analyst consensus heading into the report. A guidance gap of this magnitude relative to prior Wall Street expectations is rare, and it forces a wholesale re-rating of the analyst models underlying the stock, since a company guiding to double what analysts had modeled is effectively stating that the market's entire framework for understanding its near-term trajectory was significantly miscalibrated.
Crucially, this guidance wasn't offered as an unsupported aspiration. It was backed by record quarterly bookings of $60.7 million and an effective backlog of $100.6 million — concrete, already-secured order commitments rather than speculative forward-looking sentiment. Bookings and backlog figures of this kind provide a meaningfully higher degree of confidence in guidance than qualitative management commentary alone, since they represent orders that have already been placed and are awaited to convert into recognized revenue, giving investors real visibility into the guidance range rather than asking them to simply trust management's forecasting.
CEO Gayn Erickson's commentary provided important color on what's actually driving this inflection: accelerating demand across AI processors, silicon photonics, and power semiconductors. This detail matters enormously for how investors should interpret Aehr's growth story going forward, because it reflects a genuine diversification of the company's demand base. Aehr had previously been closely associated with electric vehicle and silicon carbide semiconductor testing, a concentration that left the company's fortunes closely tied to the EV industry's own cyclical demand swings. Erickson's characterization that the business has shifted dramatically away from that prior EV/silicon carbide concentration signals a business model transition toward a more diversified, and arguably more secularly-supported, set of end markets tied to the broader AI infrastructure buildout.
This diversification narrative is being reinforced by continued sell-side confidence: William Blair reiterated its Outperform rating following the report, signaling that at least one covering analyst views today's results and guidance as consistent with, rather than a surprising deviation from, its underlying thesis on the stock. Today's move is also benefiting from a broadly supportive semiconductor sector backdrop, with softer-than-expected producer price index data easing near-term Federal Reserve rate hike concerns, and bullish commentary from chip equipment peer ASML reinforcing the broader AI-driven equipment demand narrative across the semiconductor testing and manufacturing supply chain. For Aehr specifically, the combination of a company-specific guidance shock and a supportive sector-wide tailwind has created an unusually powerful combination of catalysts driving today's rally.






Please wait processing your request...